ASX-listed Creso Pharma receives new orders for its Anibidiol pet product line by Emma Castle December 2, 2020April 26, 2024 Three new purchase orders (POs) for Creso Pharma’s Anibidiol product line worth A$414,000 bring the total […]
Creso Pharma snags Canopy Growth founder Bruce Linton as strategic advisor by Martin Lane October 7, 2020April 26, 2024
Creso Pharma wins second big Israel order and plots Canadian expansion by Martin Lane July 13, 2020April 22, 2024